A Study To Evaluate CB-839 HCl In Combination With Carfilzomib ...
Access Denied You don't have permission to access "http://www.mayo.edu/research/clinical-trials/cls-20457165" on this server.
Reference #18.f6114576.1770819777.ae399b5
https://errors.edgesuite.net/18.f6114576.1770819777.ae399b5
Từ khóa » Cb-839 Hcl
-
Testing Of The Anti Cancer Drugs CB-839 HCl (Telaglenastat) And ...
-
CB-839 HCl In Combination With Carfilzomib And Dexamethasone ...
-
Phase 1 Trial Of MLN0128 (Sapanisertib) And CB-839 HCl ... - PubMed
-
A Phase 1 Trial Of MLN0128 (sapanisertib) And CB-839 HCl ... - NCBI
-
Phase 1 Trial Of MLN0128 (Sapanisertib) And CB-839 HCl ...
-
Trial In Progress: Phase I Dose-Escalation And Dose-Expansion ...
-
Phase 1 Trial Of MLN0128 (Sapanisertib) And CB-839 HCl ...
-
A Phase I/II Study Of AZD9291 (Osimertinib) And CB-839 ...
-
Testing Whether Cancers With Specific Mutations Respond Better To ...
-
Telaglenastat (CB-839) - Glutaminase Inhibitor
-
A Phase Ib Study Of AZD9291 (Osimertinib) And CB-839 HCl In ...
-
Safety And Tolerability Of Increasing Doses Of CB-839, A First-in-class ...
-
Testing Of The Anti Cancer Drugs CB-839 HCl ... - CenterWatch